Recommendations for evaluating the safety of medicinal products containing nanoparticles

Recommendations for evaluating the safety of medicinal products containing nanoparticles

Recommendations for preclinical safety assessment of medicinal products containing nanoparticles are presented. The recommendations provide conditions for research acute and chronic toxicity of nanotherapeutics, methods for their quantitative and qualitative assessments.

Bibliographic Details
Main Authors: R. N. Alyautdin, B. K. Romanov
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-02-01
Series:Безопасность и риск фармакотерапии
Subjects:
нанотехнологии
токсичность
лекарственное средство
nanotechnology
toxicity
drug
Online Access:https://www.risksafety.ru/jour/article/view/25

Similar Items

Similar Items